1. Treatment‐free remission with first‐ and second‐generation tyrosine kinase inhibitors
   Jorge Cortes et al, 2019, American Journal of Hematology CrossRef
2. Outcomes of unplanned tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: retrospective analysis of real-world experience in a single institution
   Masaki Iino et al, 2019, Hematology CrossRef